In order to establish if the NTHL1 p.Q82* mutation in exon 2 is associated with cancer development or influences the disease course in polyposis patients, we genotyped the gathered DNA samples using HRM analysis followed by Sanger sequencing. Here, NTHL1 is linked to cancer.